NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell … – MSN MoneyCentral
NEW YORK , Feb. 23 /PRNewswire-FirstCall/ — NeoStem, Inc. (NYSE Alternext US: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today it has signed a license …
[Read the full article here]Related News:
NeoStem Obtains Exclusive Worldwide License for Innovative Stem Cell Technology and Applications to Heal Chronic Wounds
NeoStem obtains exclusive license to innovative stem cell procedure treating musculoskeletal diseases
NeoStem Vice President Will Speak on VSELs and Emerging Stem Cell …